Population
Patients with chronic congestive heart failure
Design
Review
Authors
Loading...
Gene therapy for ECM remodeling in HF remains hypothesis-generating; leaves open prospective trials before clinical consideration.
Gene therapy targeting extracellular matrix remodeling components represents a potential future therapeutic strategy for heart failure.
Suresh C. Tyagi (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: